ID: ALA5272685

Max Phase: Preclinical

Molecular Formula: C17H16O6

Molecular Weight: 316.31

Associated Items:

Representations

Canonical SMILES:  COc1ccc2oc3cc(C)c(O)c(CO)c3c(=O)c2c1OC

Standard InChI:  InChI=1S/C17H16O6/c1-8-6-12-13(9(7-18)15(8)19)16(20)14-10(23-12)4-5-11(21-2)17(14)22-3/h4-6,18-19H,7H2,1-3H3

Standard InChI Key:  CLHDFKDJTJWRBE-UHFFFAOYSA-N

Associated Targets(non-human)

Influenza A virus 11224 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.31Molecular Weight (Monoisotopic): 316.0947AlogP: 2.47#Rotatable Bonds: 3
Polar Surface Area: 89.13Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.89CX Basic pKa: CX LogP: 2.09CX LogD: 2.09
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: 1.29

References

1. Takahashi JA, Barbosa BVR, Lima MTNS, Cardoso PG, Contigli C, Pimenta LPS..  (2021)  Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.,  46  [PMID:34438338] [10.1016/j.bmc.2021.116366]

Source